Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 41.00
Ask: 43.00
Change: 1.50 (3.70%)
Spread: 2.00 (4.878%)
Open: 41.50
High: 42.00
Low: 41.50
Prev. Close: 40.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Palintest launches Molendotech bathing water test

15 May 2018 07:00

RNS Number : 9469N
Frontier IP Group plc
15 May 2018
 

RNS REACH / RNS

AIM: FIPP

15 May 2018

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Portfolio news - Palintest launches Molendotech bathing water test

 

 

Frontier IP, which specialises in commercialising university intellectual property, today announces that Palintest, a subsidiary of FTSE 100 group Halma plc, is launching Siren BW, a water testing kit developed by portfolio company Molendotech, a spin out from the University of Plymouth.

 

It is the first commercial application for Molendotech's novel test able to identify the concentration of faecal bacteria in water. Currently, it can take two days for local authorities and environmental agencies to assess the quality of recreational water because samples must be sent to a laboratory. Palintest's field-ready kit produces a result in less than 30 minutes and is simple enough to be used at the sample point.

 

The kit is initially available in the UK and Ireland, with roll out to continental Europe and the US planned.

 

Further applications are now being developed in collaboration with Palintest to leverage the real-time availability of pathogen risk in water. It has a wide range of potential uses, including potable water and in food and beverage production.

 

Molendotech was incorporated less than a year ago to develop and commercialise the work of Simon Jackson, Professor of Environment and Human Health within the University of Plymouth's Peninsula Schools of Medicine and Dentistry.

 

Frontier IP chief executive officer Neil Crabb said: "We're delighted the agreement with Palintest, announced earlier this year, is bearing fruit so quickly. It has taken less than a year from Molendotech joining our portfolio to the commercial launch of its first product."

 

Director of Molendotech, Professor Simon Jackson, said: "Water quality is a global issue and fundamental to human and public health. Unfortunately, traditional, lab-based methods for testing water quality, particularly for faecal contamination, do not deliver the kind of rapid results required for in-situ investigation and decision-making. With this breakthrough, however, environmental agencies will be able to gain a much clearer understanding of water quality, which could lead to better and more effective management of beaches and other recreational bathing waters, and faster identification of sources of pollution."

 

Open Innovation Product Manager at Palintest Ian Leahy said: "The opportunity to bring our ability to produce rugged, simple-to-use water quality testing kits together with this exciting Molendotech innovation is a perfect example of two organisations collaborating to answer a clear customer need in the markets we already serve. For many years we sought opportunities to deliver simple, real-time microbiological risk screening at the point of use and I'm excited to say we are finally at that point now."

 

 

For more product details, please contact ian.leahy@palintest.com

 

 

ENQUIRIES

 

Frontier IP Group Plc

T: 0131 240 1251

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

andrew.johnson@frontierip.co.uk

Company website: www.frontierip.co.uk

 

M: 07464 546 025

Cenkos Securities plc (Nominated Adviser and Joint Broker)

T: 0131 220 6939

Neil McDonald / Beth McKiernan

 

Peterhouse Corporate Finance Limited (Joint Broker)

T: 020 7469 0935

Lucy Williams

 

Kreab (Financial PR)

T: 020 7074 1800

Robert Speed / Matthew Jervois

NOTES TO EDITORS

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services.

The Group looks to build and grow a portfolio of equity stakes and licence income from by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

Frontier IP and the University of Plymouth:

Frontier IP has forged a strong relationship with the University of Plymouth to commercialise intellectual property. Other collaborations include:

· Fieldwork Robotics: developing advanced soft robotics for harvesting fruit and vegetables. The technology has attracted strong industry interest.

· The Vaccine Group: work includes creating novel vaccines to prevent viruses from jumping the species barrier from animals to humans

· Pulsiv Solar: US and European patents granted on its novel technology to improve the energy efficiency of photovoltaic cells and power conversion

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGIGDUUXBBGIS
Date   Source Headline
28th Apr 20217:00 amRNSExscientia Series D funding led by SoftBank
20th Apr 20217:00 amRNSHolding(s) in Company
24th Mar 20217:00 amRNSUnaudited Half Year Results
19th Mar 20217:00 amRNSFieldwork Robotics raises £675,000
18th Mar 20217:00 amRNSHolding(s) in Company
16th Mar 20217:00 amRNSAlusid - appoints David Taylor CBE to the Board
12th Mar 202112:27 pmRNSHolding(s) in Company
12th Mar 20217:00 amRNSHolding(s) in Company
11th Mar 20217:00 amRNSinSignals Neurotech receives EUR100,000 investment
9th Mar 20217:00 amRNSUN awards $250,000 grant to AquaInSilico
8th Mar 20219:05 amRNSSecond Price Monitoring Extn
8th Mar 20219:00 amRNSPrice Monitoring Extension
4th Mar 20217:30 amRNSExscientia completes $100 million Series C funding
22nd Feb 20217:00 amRNSPulsiv Solar raises £890,000
16th Feb 20217:00 amRNSPublication of newsletter
16th Feb 20217:00 amRNSHolding(s) in Company
1st Feb 20217:00 amRNSFrontier IP supports breakthrough technology
18th Jan 20217:00 amRNSHolding(s) in Company
15th Jan 20217:00 amRNSAppointment of Darren Winter
11th Jan 20217:00 amRNSPortfolio news – Elute Intelligence raises £250k
29th Dec 20201:44 pmRNSHolding(s) in Company
17th Dec 202012:30 pmRNSResult of AGM
1st Dec 20207:00 amRNSCambridge Raman participates in EUR 5m project
20th Nov 20207:00 amRNSPosting of Annual Report and Notice of AGM
16th Nov 20207:00 amRNSFrontier IP: recording of annual results webcast
16th Nov 20207:00 amRNSPortfolio news – Fieldwork SIF grant
13th Nov 20202:03 pmRNSHolding(s) in Company
10th Nov 20207:00 amRNSAlusid - £125,000 backing from UK Future Fund
9th Nov 20206:03 pmRNSDirectors’ Dealings
6th Nov 20203:07 pmRNSHolding(s) in Company
5th Nov 20202:34 pmRNSGrant of Options
5th Nov 20207:00 amRNSAnnual results webcast hosted by LSE
5th Nov 20207:00 amRNSFinal Results
26th Oct 20207:00 amRNSPublication of newsletter
15th Oct 20207:00 amRNSTVG collaboration - Pirbright & ECO Animal Health
21st Sep 20207:00 amRNSBonduelle collaboration with Fieldwork Robotics
16th Sep 20207:00 amRNSUK Gov Future Fund invests £360k in Nandi Proteins
14th Sep 20207:00 amRNSInnovate UK backs Fieldwork Robotics with grant
9th Sep 20205:11 pmRNSHolding(s) in Company
7th Sep 20207:00 amRNSSoftware Commercialisation Director appointment
1st Sep 20207:00 amRNSElute Intelligence Patent Reader launched
24th Aug 20205:48 pmRNSHolding(s) in Company
10th Aug 20207:00 amRNSUK Gov Future Fund invests £250,000 in Pulsiv
5th Aug 20206:24 pmRNSHolding(s) in Company
4th Aug 20202:45 pmRNSHolding(s) in Company
31st Jul 20205:00 pmRNSTotal Voting Rights
30th Jul 202011:45 amRNSHolding(s) in Company
29th Jul 20202:46 pmRNSHolding(s) in Company
29th Jul 20209:11 amRNSHolding(s) in Company
28th Jul 20205:22 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.